Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Equity (2016 - 2025)

Historic Return on Equity for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to 2.47%.

  • Traws Pharma's Return on Equity fell 51000.0% to 2.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.47%, marking a year-over-year decrease of 51000.0%. This contributed to the annual value of 13.59% for FY2024, which is 146300.0% up from last year.
  • Per Traws Pharma's latest filing, its Return on Equity stood at 2.47% for Q3 2025, which was down 51000.0% from 2.84% recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Return on Equity ranged from a high of 11.11% in Q1 2025 and a low of 2.84% during Q2 2025
  • For the 5-year period, Traws Pharma's Return on Equity averaged around 0.43%, with its median value being 0.61% (2021).
  • Within the past 5 years, the most significant YoY rise in Traws Pharma's Return on Equity was 134300bps (2025), while the steepest drop was -56200bps (2025).
  • Traws Pharma's Return on Equity (Quarter) stood at 0.34% in 2021, then plummeted by -85bps to 0.64% in 2022, then tumbled by -153bps to 1.61% in 2023, then skyrocketed by 625bps to 8.46% in 2024, then plummeted by -129bps to 2.47% in 2025.
  • Its last three reported values are 2.47% in Q3 2025, 2.84% for Q2 2025, and 11.11% during Q1 2025.